Delivery Order SPE2DB22D3301-SPE2DB24FX5EE
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL Vial 10mL, a critical diabetes medication. The total ceiling value of the contract is $1,809.60, with a period of performance through January 30, 2025. The contract was awarded on a firm-fixed price basis without any set-aside designation, indicating open...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin aspart 100 unit/mL vials. The contract has a ceiling value of $3,169.20 and a period of performance through June 10, 2025. The contract is not set aside and was awarded on June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Insulin Aspart 100 Unit/mL in 10 mL vials. The contract has a ceiling value of $1,097.40 and an ultimate completion date of May 30, 2025. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4564617692 units of Insulin Aspart 100 Unit/mL Vial 10mL. The award is a Firm Fixed Price contract with a ceiling value of $11,209.30 and a performance period ending on May 16, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $2,189.41 and a period of performance ending on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a critical pharmaceutical product, to support military healthcare needs. The contract has a ceiling value of $3,417.48 and a period of performance through January 24, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10 milliliter vials of Insulin Aspart 100 Unit/mL, a medication used to treat diabetes. The contract has a ceiling value of $3,127.45 and a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,743,151 units of Insulin Aspart 100 Unit/mL in 10 mL vials, with a ceiling value of $4,266.02. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2024. The contract is not designated as a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 10 milliliter vials of insulin aspart 100 unit/mL. The contract has a firm fixed price of $7,419.16 and an ultimate completion date of July 16, 2025. The award was made on July 15, 2025, and the contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $3,640.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Insulin Aspart 100 Unit/mL Vial 10mL, a type of insulin medication. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 7, 2025. This award is not designated as a set-aside contract. The contract is part of a larger...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX5EEDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Insulin Aspart 100 Unit/mL Vial, 10 mL. The contract has a ceiling value of $1,175.27 and a period of performance through November 13, 2023. The contract is a firm fixed-price delivery order type, with no set-aside requirements indicated. AmerisourceBergen Drug Corp is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support Medical, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/9/23 |